RESUMEN
BACKGROUND: We sought to evaluate height in white adults with hemochromatosis. METHODS: We analyzed the height of (1) post-screening examination participants with HFE p.C282Y/p.C282Y (rs1800562) and wt/wt (absence of p.C282Y and p.H63D (rs1799945)) and (2) referred hemochromatosis probands with p.C282Y/p.C282Y. RESULTS: There were 762 participants (270 p.C282Y/p.C282Y, 492 wt/wt; 343 men, 419 women) and 180 probands (104 men, 76 women). Median height of male participants with p.C282Y/p.C282Y or wt/wt was 177.8 cm. Median height of female participants was greater in those with p.C282Y/p.C282Y than wt/wt (165.1 cm vs 162.6 cm, respectively; p = 0.0298). Median height of p.C282Y/p.C282Y participants and probands was the same (men 177.8 cm; women 165.1 cm). Regressions on height of male and female participants revealed no associations with HFE genotype and inverse and positive associations with age and weight, respectively. Height of female participants was positively and inversely associated with transferrin saturation and serum ferritin, respectively. Regressions on height of male and female probands revealed positive associations with weight. CONCLUSIONS: The height of men with HFE p.C282Y/p.C282Y and wt/wt does not differ significantly. The height of female participants was greater in those with p.C282Y/p.C282Y than wt/wt. We found no independent association of HFE genotype with the height of men or women.
Asunto(s)
Estatura , Hemocromatosis , Población Blanca , Adulto , Femenino , Humanos , Masculino , Estatura/etnología , Estatura/genética , Ferritinas , Genotipo , Hemocromatosis/diagnóstico , Hemocromatosis/etnología , Hemocromatosis/genética , Proteína de la Hemocromatosis/genética , Antígenos de Histocompatibilidad Clase I/genética , Hierro , Población Blanca/genéticaAsunto(s)
COVID-19/mortalidad , Anemia de Células Falciformes/epidemiología , Anemia de Células Falciformes/virología , Pueblo Asiatico/estadística & datos numéricos , Población Negra/estadística & datos numéricos , COVID-19/sangre , COVID-19/etnología , Etnicidad/estadística & datos numéricos , Femenino , Hemocromatosis/epidemiología , Hemocromatosis/etnología , Hemocromatosis/virología , Humanos , Irlanda/etnología , Masculino , Grupos Minoritarios/estadística & datos numéricos , Pandemias , Factores de Riesgo , SARS-CoV-2/aislamiento & purificación , Reino Unido/epidemiologíaRESUMEN
BACKGROUND: Therapeutic phlebotomy is the standard treatment of hereditary hemochromatosis (HH), the most common genetic disease in people of Northern European descent. Red cell concentrates from HH donors have been reported safe for transfusion, but little data is available on the storage properties of platelet concentrates from HH donors. STUDY DESIGN AND METHODS: Whole blood was collected from 10 healthy individuals and 10 newly diagnosed HH patients with elevated serum ferritin. Platelet-rich plasma (PRP) was prepared and split into four 20-mL units. Platelet quality tests were performed on days 0, 1, 3, 5, and 7 of storage, including platelet aggregation (ADP, arachidonic acid, collagen, and epinephrine agonists), blood gas analysis, flow cytometry (CD41, CD42b, and CD62P expression), and ELISA (sCD40L and sCD62p in supernatant). RESULTS: Mean serum ferritin levels were higher in HH patients than in controls (847.5 vs 45.8 ng/mL, P < .001). Overall, no difference in quality test results was observed between the two study groups over 7-day storage (P > .05), including blood gas analysis, platelet aggregation, and expression of surface (CD62p and CD42b) and secreted (sCD62P and sCD40L) activation markers. Expected alterations in metabolic (CO2 and glucose decrease, O2 and lactate increase, P < .001) and platelet activation markers (CD42b decrease, CD62P increase, P < .05) over time were observed in both groups. CONCLUSION: Although these findings indicate that platelets of individuals with HH are comparable to platelets from healthy donors, more extensive studies are needed before definite conclusions can be drawn.
Asunto(s)
Donantes de Sangre/estadística & datos numéricos , Plaquetas/citología , Conservación de la Sangre/métodos , Hemocromatosis/diagnóstico , Adulto , Análisis de los Gases de la Sangre/métodos , Plaquetas/fisiología , Conservación de la Sangre/estadística & datos numéricos , Femenino , Ferritinas/sangre , Citometría de Flujo/métodos , Voluntarios Sanos , Hemocromatosis/sangre , Hemocromatosis/etnología , Hemocromatosis/terapia , Humanos , Masculino , Persona de Mediana Edad , Selectina-P/metabolismo , Flebotomía/métodos , Activación Plaquetaria/fisiología , Agregación Plaquetaria/fisiología , Pruebas de Función Plaquetaria/métodos , Complejo GPIb-IX de Glicoproteína Plaquetaria/metabolismo , Plasma Rico en Plaquetas/metabolismoRESUMEN
Background: African Americans are at increased risk of iron deficiency (ID) but also have higher serum ferritin (SF) concentrations than those of the general population. The Hemochromatosis and Iron Overload Screening (HEIRS) Study was a multicenter study of ethnically diverse participants that tested for the hemochromatosis (HFE) C282Y genotype and iron status.Objective: We sought to determine the prevalence and predictors of ID (SF concentration ≤15 µg/L) and elevated iron stores (SF concentration >300 µg/L) in HEIRS women of reproductive age (25-44 y).Design: The HEIRS Study was a cross-sectional study of iron status and HFE mutations in primary care patients at 5 centers in the United States and Canada. We analyzed data for women of reproductive age according to whether or not they were pregnant or breastfeeding at the time of the study.Results: ID was present in 12.5% of 20,080 nonpregnant and nonbreastfeeding women compared with 19.2% of 1962 pregnant or breastfeeding women (P < 0.001). Asian American ethnicity (OR ≤0.9; P ≤ 0.049) and HFE C282Y (OR ≤0.84; P ≤ 0.060) were independently associated with a decreased risk of ID in nonpregnant and nonbreastfeeding women and in pregnant or breastfeeding women. Hispanic ethnicity (OR: 1.8; P < 0.001) and African American ethnicity (OR: 1.6; P < 0.001) were associated with an increased risk of ID in nonpregnant and nonbreastfeeding women. Elevated iron stores were shown in 1.7% of nonpregnant and nonbreastfeeding women compared with 0.7% of pregnant or breastfeeding women (P = 0.001). HFE C282Y homozygosity had the most marked independent association with elevated iron stores in nonpregnant and nonbreastfeeding women and in pregnant or breastfeeding women (OR >49.0; P < 0.001), but African American ethnicity was also associated with increased iron stores in both groups of women (OR >2.0; P < 0.001). Asian American ethnicity (OR: 1.8; P = 0.001) and HFE C282Y heterozygosity (OR: 1.9; P = 0.003) were associated with increased iron stores in nonpregnant and nonbreastfeeding women.Conclusions: Both ID and elevated iron stores are present in women of reproductive age and are influenced by ethnicity and HFE C282Y. Efforts to optimize iron status should keep these findings in view. This study was registered at clinicaltrials.gov as NCT03276247.
Asunto(s)
Anemia Ferropénica/etnología , Etnicidad/genética , Hemocromatosis/etnología , Hierro/sangre , Estado Nutricional , Adulto , Anemia Ferropénica/sangre , Anemia Ferropénica/genética , Canadá/epidemiología , Femenino , Ferritinas/sangre , Hemocromatosis/sangre , Hemocromatosis/genética , Proteína de la Hemocromatosis/genética , Proteína de la Hemocromatosis/metabolismo , Homocigoto , Humanos , Deficiencias de Hierro , Mutación , Prevalencia , Estados Unidos/epidemiologíaRESUMEN
BACKGROUND: 373 black participants had elevated screening and post-screening serum ferritin (SF) (> 300 µg/L men; > 200 µg/L women). MATERIAL AND METHODS: We retrospectively studied SF and post-screening age; sex; body mass index; transferrin saturation (TS); ALT; AST; GGT; elevated C-reactive protein; ß-thalassemia; neutrophils; lymphocytes; monocytes; platelets; metacarpophalangeal joint hypertrophy; hepatomegaly; splenomegaly; diabetes; HFE H63D positivity; iron/alcohol intakes; and blood/erythrocyte transfusion units. Liver disease was defined as elevated ALT or AST. We computed correlations of SF and TS with: age; body mass index; ALT; AST; GGT; C-reactive protein; blood cell counts; and iron/alcohol. We compared participants with SF > 1,000 and ≤ 1,000 µg/L and performed regressions on SF. RESULTS: There were 237 men (63.5%). Mean age was 55 ± 13 (SD) y. 143 participants had liver disease (62 hepatitis B or C). There were significant correlations of SF: TS, ALT, AST, GGT, and monocytes (positive); and SF and TS with platelets (negative). 22 participants with SF > 1,000 µg/L had significantly higher median TS, ALT, and AST, and prevalences of anemia and transfusion > 10 units; and lower median platelets. Regression on SF revealed significant associations: TS; male sex; age; GGT; transfusion units (positive); and splenomegaly (negative) (p < 0.0001, 0.0016, 0.0281, 0.0025, 0.0001, and 0.0096, respectively). Five men with SF > 1,000 µg/L and elevated TS had presumed primary iron overload (hemochromatosis). Four participants had transfusion iron overload. CONCLUSION: Persistent hyperferritinemia in 373 black adults was associated with male sex, age, TS, GGT, and transfusion. 2.4% had primary iron overload (hemochromatosis) or transfusion iron overload.
Asunto(s)
Ferritinas/sangre , Hemocromatosis/sangre , Sobrecarga de Hierro/sangre , Adulto , Negro o Afroamericano/genética , Anciano , Alabama/epidemiología , Biomarcadores/sangre , Transfusión Sanguínea , Comorbilidad , Femenino , Hemocromatosis/etnología , Hemocromatosis/genética , Hemocromatosis/terapia , Humanos , Sobrecarga de Hierro/etnología , Sobrecarga de Hierro/genética , Sobrecarga de Hierro/terapia , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Retrospectivos , Factores de Riesgo , Factores Sexuales , Transferrina/metabolismo , Resultado del Tratamiento , Regulación hacia Arriba , gamma-Glutamiltransferasa/sangreRESUMEN
Juvenile hemochromatosis is a rare but the most severe form of hereditary hemochromatosis which develops due to mutations in the HJV or HAMP genes. It presents in the early adulthood mainly as cardiomyopathy, hypogonadism and liver fibrosis. Unlike hereditary hemochromatosis due to HFE mutation, hepatocellular carcinoma is not known to be associated with juvenile hemochromatosis. Here, we report a patient of Arab ancestry who presented with severe cardiomyopathy. Sequence analysis of the HJV gene followed by homozygosity mapping, identified a previously undescribed homozygous missense variation in exon 3 (c.497A > G; p.H166R) in both the proband and his clinically asymptomatic brother. The former, later developed hepatocellular carcinoma. To the best of our knowledge, neither the mutation identified in our patient, nor a case of juvenile hemochromatosis with hepatocellular carcinoma has been reported before.
Asunto(s)
Carcinoma Hepatocelular/genética , Proteína de la Hemocromatosis/genética , Hemocromatosis/congénito , Neoplasias Hepáticas/genética , Mutación Missense , Adulto , Árabes , Carcinoma Hepatocelular/complicaciones , Carcinoma Hepatocelular/diagnóstico , Exones , Hemocromatosis/complicaciones , Hemocromatosis/diagnóstico , Hemocromatosis/etnología , Hemocromatosis/genética , Homocigoto , Humanos , Neoplasias Hepáticas/complicaciones , Neoplasias Hepáticas/diagnóstico , MasculinoRESUMEN
A genome-wide association study was performed on 1130 premenopausal women to detect common variants associated with three serum iron-related phenotypes. Total iron binding capacity was strongly associated (p=10(-14)) with variants in and near the TF gene (transferrin), the serum iron transporting protein, and with variants in HFE (p=4×10(-7)), which encodes the human hemochromatosis gene. Association was also detected between percent iron saturation (p=10(-8)) and variants in the chromosome 6 region containing both HFE and SLC17A2, which encodes a phosphate transport protein. No significant associations were detected with serum iron, but variants in HFE were suggestive (p=10(-6)). Our results corroborate prior studies in older subjects and demonstrate that the association of these genetic variants with iron phenotypes can be detected in premenopausal women.
Asunto(s)
Hemocromatosis/genética , Antígenos de Histocompatibilidad Clase I/genética , Hierro/sangre , Proteínas de la Membrana/genética , Premenopausia/genética , Proteínas Cotransportadoras de Sodio-Fosfato de Tipo I/genética , Transferrina/genética , Adulto , Cromosomas Humanos Par 6/química , Femenino , Expresión Génica , Estudio de Asociación del Genoma Completo , Hemocromatosis/sangre , Hemocromatosis/etnología , Hemocromatosis/patología , Proteína de la Hemocromatosis , Humanos , Persona de Mediana Edad , Fenotipo , Polimorfismo Genético , Premenopausia/sangre , Análisis de Secuencia de ADN , Población BlancaAsunto(s)
Péptidos Catiónicos Antimicrobianos/biosíntesis , Hemocromatosis/genética , Antígenos de Histocompatibilidad Clase I/genética , Proteínas de la Membrana/genética , Mutación Missense , Mutación Puntual , Adolescente , Adulto , Anemia Hipocrómica/genética , Péptidos Catiónicos Antimicrobianos/genética , Niño , Consanguinidad , Europa (Continente)/etnología , Femenino , Ferritinas/sangre , Factor 15 de Diferenciación de Crecimiento/sangre , Factor 15 de Diferenciación de Crecimiento/fisiología , Haplotipos/genética , Hemocromatosis/epidemiología , Hemocromatosis/etnología , Proteína de la Hemocromatosis , Células Hep G2 , Hepcidinas , Humanos , India/epidemiología , Masculino , Persona de Mediana Edad , Regulación hacia Arriba , Adulto Joven , Globinas beta/genéticaRESUMEN
The aim of this study was to assess the frequencies of three hemochromatosis gene (HFE) mutations in ethnic Roma/Gypsies in Slovakia. A cohort of 367 individuals representing general population and not preselected for health status was genotyped by TaqMan real-time PCR assay for C282Y, H63D and S65C mutations in HFE gene. A unique genetic profile was revealed: C282Y is found in the highest frequency of all Central European countries (4.90%), while the frequency of H63D mutation (4.09%) is lower than any reported in Europe so far. S65C mutation was not present in the cohort. These mutation frequencies can be explained rather by gene influx and genetic isolation than by genetic inheritance from a former Roma/Gypsy homeland.
Asunto(s)
Hemocromatosis , Antígenos de Histocompatibilidad Clase I/genética , Proteínas de la Membrana/genética , Romaní , Estudios de Cohortes , Femenino , Frecuencia de los Genes , Genotipo , Hemocromatosis/etnología , Hemocromatosis/genética , Proteína de la Hemocromatosis , Humanos , Masculino , Mutación , Tasa de Mutación , Reacción en Cadena en Tiempo Real de la Polimerasa , Eslovaquia/epidemiología , Población BlancaRESUMEN
Frequent blood donors become iron deficient. HFE mutations are present in over 30% of donors. A 24-month study of 888 first time/reactivated donors and 1537 frequent donors measured haemoglobin and iron status to assess how HFE mutations impact the development of iron deficiency erythropoiesis. Donors with two HFE mutations had increased baseline haemoglobin and iron stores as did those with one mutation, albeit to a lesser extent. Over multiple donations haemoglobin and iron status of donors with HFE mutations paralleled those lacking mutations. The prevalence of HFE mutations was not increased in higher intensity donors. Thus, in general, HFE mutations do not temper donation-induced changes in haemoglobin and iron status. However, in Black donors there was an increase of H63D carriers at baseline, from 3·7% in first time/reactivated donors to 15·8% in frequent donors, suggesting that the relative effects of HFE mutations on iron absorption may vary between racial/ethnic groups. In secondary analyses, venous haemoglobin decreased more slowly in donors with ferritin ≥12µg/l; and haemoglobin recovery time was shorter in donors with reticulocyte haemoglobin (CHr) ≥32·6pg, indicating that these biochemical measures are better indicators of a donor's response to phlebotomy than their HFE mutation status.
Asunto(s)
Donantes de Sangre , Hemocromatosis/sangre , Hemoglobinas/metabolismo , Antígenos de Histocompatibilidad Clase I/genética , Hierro/sangre , Proteínas de la Membrana/genética , Adolescente , Adulto , Anciano , Anemia Ferropénica/epidemiología , Anemia Ferropénica/etiología , Anemia Ferropénica/prevención & control , Recuento de Células Sanguíneas , Donantes de Sangre/legislación & jurisprudencia , Etnicidad , Femenino , Ferritinas/sangre , Estudios de Seguimiento , Genotipo , Hemocromatosis/etnología , Proteína de la Hemocromatosis , Antígenos de Histocompatibilidad Clase I/fisiología , Humanos , Deficiencias de Hierro , Masculino , Proteínas de la Membrana/fisiología , Persona de Mediana Edad , Mutación , Receptores de Transferrina/análisis , Recuento de Reticulocitos , Factores de Tiempo , Estados Unidos/epidemiología , Adulto JovenRESUMEN
Hereditary hemochromatosis (HH) refers to several inherited disorders of iron metabolism leading to tissue iron overload. Classical HH is associated with mutations in HFE (C282Y homozygotes or C282Y/H63D compound heterozygotes) and is almost exclusively found in populations of northern European descent. Non-HFE-associated HH is caused by mutations in other recently identified genes involved in iron metabolism. Hepcidin is an iron regulatory hormone that inhibits ferroportin-mediated iron export from enterocytes and macrophages. Defective hepcidin gene expression or function may underlie most forms of HH. Target organs and tissues affected by HH include the liver, heart, pancreas, joints, and skin, with cirrhosis and diabetes mellitus representing late signs of disease in patients with markedly elevated liver iron concentration. Recently, we have encountered the rare representation of this disease of the oral cavity associated with generalized burning sensation of the tongue. The diagnosis was established accidently, from the lab investigations, otherwise the patient was healthy and free from classical signs and symptoms of the disease. The patient was adequately treated by phlebotomy. To conclude, all patients with a chief complaint of burning sensation of the oral cavity and tongue should be adequately screened for hereditary hemochromatosis to prevent the associated mortality and morbidity with the hemochromatosis.
Asunto(s)
Hemocromatosis/genética , Enfermedades de la Lengua/genética , Adulto , Factores de Edad , Femenino , Ferritinas/sangre , Hemocromatosis/sangre , Hemocromatosis/etnología , Hemocromatosis/terapia , Humanos , Persona de Mediana Edad , Flebotomía , Arabia Saudita , Factores Sexuales , Enfermedades de la Lengua/sangre , Enfermedades de la Lengua/etnología , Enfermedades de la Lengua/terapia , Transferrina/análisis , Estados Unidos/epidemiología , Población Blanca/genéticaAsunto(s)
Hemocromatosis/genética , Antígenos de Histocompatibilidad Clase I/genética , Homocigoto , Hígado/metabolismo , Proteínas de la Membrana/genética , Mutación , Ferritinas/sangre , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Pruebas Genéticas , Hemocromatosis/sangre , Hemocromatosis/diagnóstico , Hemocromatosis/etnología , Proteína de la Hemocromatosis , Humanos , Hierro/metabolismo , Hígado/patología , Linaje , Fenotipo , España/epidemiología , Transferrina/metabolismo , Población Blanca/genéticaRESUMEN
BACKGROUND: The significance of H63D homozygosity remains uncertain, although it is associated with a tendency for patients to develop iron overload. AIMS: To study the prevalence of homozygotic H63D mutation in patients with phenotypic hemochromatosis (PH) and to compare the results with those of the general population and with patients with porphyria cutanea tarda (PCT) in the Basque Country, Spain. A secondary aim was to evaluate the differences in phenotypic expression and liver injury according to different genotypes in the PH cohort. METHODS: Mutations of the HFE gene were obtained by polymerase chain reaction (PCR). Forty consecutive patients diagnosed with PH, 116 controls and 54 patients with PCT were included in the study. We performed liver biopsies, measured liver iron concentration (LIC), by atomic spectrophotometry, serum ferritin and transferrin saturation, and compared the histology according to the genotype. RESULTS: The H63D homozygote mutation was identified in 7.76% of the control group, in 7.50% of the PH group, and in 11.11% of patients with PCT (P > 0.05). The C282Y/C282Y mutation was present in 50% of patients with PH, and LIC was identified in 15/20. The LIC in C282Y/C282Y patients was higher than in H63D/H63D patients (P = 0.26), while H63D homozygosis caused greater iron overload in PH patients than other genotypes. All the C282Y/C282Y genotype patients had elevated serum ferritin and transferrin saturation. The H63D homozygotes had high ferritin, but two out of three had normal transferrin saturation. Six of the eight patients with high-grade fibrosis and genetic study results were found to be C282Y/C282Y. CONCLUSIONS: The prevalence of H63D mutation in patients with PH in our region does not differ from that of the general Basque population.
Asunto(s)
Hemocromatosis/genética , Antígenos de Histocompatibilidad Clase I/genética , Homocigoto , Hígado/metabolismo , Proteínas de la Membrana/genética , Mutación , Población Blanca/genética , Adulto , Anciano , Anciano de 80 o más Años , Biopsia , Femenino , Ferritinas/sangre , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Hemocromatosis/sangre , Hemocromatosis/etnología , Proteína de la Hemocromatosis , Humanos , Hierro/metabolismo , Hígado/patología , Masculino , Persona de Mediana Edad , Fenotipo , Reacción en Cadena de la Polimerasa , Porfiria Cutánea Tardía/sangre , Porfiria Cutánea Tardía/etnología , Porfiria Cutánea Tardía/genética , Estudios Retrospectivos , España/epidemiología , Espectrofotometría Atómica , Transferrina/metabolismoRESUMEN
PURPOSE: Hereditary hemochromatosis has not been fully evaluated in the non-Ashkenazi population and is considered to be relatively rare. After ascertaining three unrelated hereditary hemochromatosis families of North African Jewish origin with the HFE C282Y/C282Y genotype, we evaluated the C282Y and H63D allele frequencies among the different Jewish ethnic groups in Israel, in particular North African Jews. METHODS: Data were collected from three Israeli Medical Centers. North African, Oriental, Yemenite, and Sephardic Jewish healthy individuals were assessed for the C282Y and H63D alleles. RESULTS: The C282Y allele frequency was 1.02% (6/586 chromosomes), and the H63D allele frequency was 13.82% (81/586 chromosomes) in the North African Jewish group. The C282Y allele was not detected in the other non-Ashkenazi groups. The H63D allele frequency was 12.5% (38/304 chromosomes) in Oriental Jews, 14.9% (14/94 chromosomes) in Yemenite Jews, and 9.3% (11/118 chromosomes) in Sephardic Jews. DISCUSSION: Hereditary hemochromatosis is underrecognized among North African Jews, who have carrier frequencies of 1/58 and 1/4 for C282Y and H63D, respectively. HFE-hereditary hemochromatosis is not rare among this population as currently thought and merits increased awareness to prevent endpoint disease. The frequent occurrence of beta-thalassemia trait and HFE-H63D in non-Ashkenazi Jews raises the possibility of genetic interactions contributing to iron overload when coinherited and requires further evaluation.
Asunto(s)
Hemocromatosis/etnología , Hemocromatosis/genética , Antígenos de Histocompatibilidad Clase I/genética , Judíos/genética , Proteínas de la Membrana/genética , África del Norte/etnología , Alelos , Frecuencia de los Genes , Proteína de la Hemocromatosis , Humanos , Israel , Marruecos/etnologíaRESUMEN
Hemochromatosis comprises a group of inherited disorders resulting from mutations of genes involved in regulating iron metabolism. The multicenter, multi-ethnic Hemochromatosis and Iron Overload Screening (HEIRS) Study screened approximately 100,000 participants in the US and Canada, testing for HFE mutations, serum ferritin and transferrin saturation. As in other studies, HFE C282Y homozygosity was common in Caucasians but rare in other ethnic groups, and there was a marked heterogeneity of disease expression in C282Y homozygotes. Nevertheless, this genotype was often associated with elevations of serum ferritin and transferrin saturation and with iron stores of more than four grams in men but not in women. If liver biopsy was performed, in some cases because of evidence of hepatic dysfunction, fibrosis or cirrhosis was often found. Combined elevations of serum ferritin and transferrin saturation were observed in non-C282Y homozygotes of all ethnic groups, most prominently Asians, but not often with iron stores of more than four grams. Future studies to discover modifier genes that affect phenotypic expression in C282Y hemochromatosis should help identify patients who are at greatest risk of developing iron overload and who may benefit from continued monitoring of iron status to detect progressive iron loading.
Asunto(s)
Hemocromatosis/genética , Antígenos de Histocompatibilidad Clase I/genética , Tamizaje Masivo/estadística & datos numéricos , Proteínas de la Membrana/genética , Adulto , Anciano , Anciano de 80 o más Años , Péptidos Catiónicos Antimicrobianos/deficiencia , Péptidos Catiónicos Antimicrobianos/genética , Péptidos Catiónicos Antimicrobianos/fisiología , Canadá/epidemiología , Etnicidad/genética , Femenino , Ferritinas/sangre , Heterogeneidad Genética , Genotipo , Hemocromatosis/epidemiología , Hemocromatosis/etnología , Hemocromatosis/patología , Proteína de la Hemocromatosis , Hepcidinas , Humanos , Absorción Intestinal/genética , Absorción Intestinal/fisiología , Hierro/sangre , Sobrecarga de Hierro/etiología , Sobrecarga de Hierro/prevención & control , Hierro de la Dieta/farmacocinética , Hígado/patología , Masculino , Persona de Mediana Edad , Mutación Missense , Mutación Puntual , Prevalencia , Caracteres Sexuales , Transferrina/análisis , Estados Unidos/epidemiologíaRESUMEN
BACKGROUND: The HEmochromatosis and IRon Overload Screening (HEIRS) Study provided data on a racially, ethnically and geographically diverse cohort of participants in North America screened from primary care populations. METHODS: A total of 101,168 participants were screened by testing for HFE C282Y and H63D mutations, and measuring serum ferritin concentration and transferrin saturation. In the present review, lessons from the HEIRS Study are highlighted in the context of the principles of screening for a medical disease as previously outlined by the World Health Organization. RESULTS: Genetic testing is well accepted, with minimal risk of discrimination. Transferrin saturation has high biological variability and relatively low sensitivity to detect HFE C282Y homozygotes, which limits its role as a screening test. Symptoms attributable to HFE C282Y homozygosity are no more common in individuals identified by population screening than in control subjects. CONCLUSIONS: Generalized population screening in a primary care population as performed in the HEIRS Study is not recommended. There may be a role for focused screening in Caucasian men, with some debate regarding genotyping followed by phenotyping, or phenotyping followed by genotyping.
Asunto(s)
Pruebas Genéticas , Hemocromatosis/diagnóstico , Hemocromatosis/etnología , Hemocromatosis/genética , Tamizaje Masivo , Etnicidad , Femenino , Predisposición Genética a la Enfermedad/etnología , Pruebas Genéticas/ética , Genotipo , Hemocromatosis/metabolismo , Humanos , Hierro/metabolismo , Masculino , Tamizaje Masivo/ética , Tamizaje Masivo/métodos , Tamizaje Masivo/normas , Mutación , América del NorteRESUMEN
Heme carrier protein 1 (HCP1) has been identified as a possible heme carrier by in vitro analysis. To determine the association of mutations within the HCP1 gene with iron phenotypes, we examined the entire coding region of the HCP1 gene in 788 US and Canadian participants selected from the Hemochromatosis and Iron Overload Screening (HEIRS) Study using denaturing high-performance liquid chromatography. We sequenced the exon and flanking intronic regions if variants were detected. We tested 298 non-C282Y homozygotes from four racial/ethnic backgrounds (White, Black, Asian, and Hispanic) selected because they had high serum ferritin (SF) and transferrin saturations (TS). As controls, we chose 300 other random participants of the same racial/ethnic backgrounds from the same geographic locations. From the 333 HEIRS Study C282Y homozygotes, we selected 75 based on high SF and TS, 75 based on low SF and TS; and 75 were selected randomly as controls. Thirty-five of the randomly selected C282Y homozygotes were also included in the high and the low SF and TS groups due to numerical limitations. We identified eight different HCP1 genetic variants; each occurred in a heterozygous state. Except one, each was found in a single HEIRS Study participant. Thus, HCP1 variants are infrequent in the populations that we tested. Five HEIRS Study participants had non-synonymous, coding region HCP1 variants. Each of these five had TS above the 84th gender- and ethnic/racial group-specific percentile (TS percentiles: 84.7, 91.3, 97.9, 99.5, and 99.9).
Asunto(s)
Hemocromatosis/genética , Sobrecarga de Hierro/genética , Proteínas de Transporte de Membrana/genética , Canadá/epidemiología , Estudios de Casos y Controles , Cromatografía Líquida de Alta Presión , Estudios de Cohortes , Análisis Mutacional de ADN , Etnicidad/genética , Exones/genética , Hemocromatosis/sangre , Hemocromatosis/etnología , Proteína de la Hemocromatosis , Heterocigoto , Antígenos de Histocompatibilidad Clase I/genética , Humanos , Intrones/genética , Hierro/sangre , Sobrecarga de Hierro/sangre , Sobrecarga de Hierro/etnología , Proteínas de la Membrana/genética , Proteínas de Transporte de Membrana/fisiología , Mutación Missense , Desnaturalización de Ácido Nucleico , Mutación Puntual , Transportador de Folato Acoplado a Protón , Grupos Raciales/genética , Muestreo , Transferrina/análisis , Estados Unidos/epidemiologíaRESUMEN
Only a small proportion of genetic variation in complex traits has been explained by SNPs from genome-wide association studies (GWASs). We report the results from two GWASs for serum markers of iron status (serum iron, serum transferrin, transferrin saturation with iron, and serum ferritin), which are important in iron overload (e.g., hemochromatosis) and deficiency (e.g., anemia) conditions. We performed two GWASs on samples of Australians of European descent. In the first GWAS, 411 adolescent twins and their siblings were genotyped with 100K SNPs. rs1830084, 10.8 kb 3' of TF, was significantly associated with serum transferrin (p total association test = 1.0 x 10(-9); p within-family test = 2.2 x 10(-5)). In the second GWAS on an independent sample of 459 female monozygotic (MZ) twin pairs genotyped with 300K SNPs, we found rs3811647 (within intron 11 of TF, HapMap CEU r(2) with rs1830084 = 0.86) was significantly associated with serum transferrin (p = 3.0 x 10(-15)). In the second GWAS, we found two additional and independent SNPs on TF (rs1799852 and rs2280673) and confirmed the known C282Y mutation in HFE to be independently associated with serum transferrin. The three variants in TF (rs3811647, rs1799852 and rs2280673) plus the HFE C282Y mutation explained approximately 40% of genetic variation in serum transferrin (p = 7.8 x 10(-25)). These findings are potentially important for our understanding of iron metabolism and of regulation of hepatic protein secretion, and also strongly support the hypothesis that the genetic architecture of some endophenotypes may be simpler than that of disease.